This edition of the COVID-19 Impact on Indian states & Malaysia covers news articles from September 1, 2021 – September 13, 2021.
13th September 2021 | Money Control
With over 11,000 COVID-19 vaccine shots given on September 12, the cumulative number of doses administered in the national capital so far has reached 15,022,686, according to the Co-WIN portal. The number of doses was low since a majority of government vaccination centres are shut on Sundays. Of the total 15,022,686 doses administered, 4,384,838 are second doses, according to the portal.
13th September 2021 | The Free Press Journal
In the ongoing vaccination drive, Maharashtra on September 12 has vaccinated 201,002 people through 1,175 sessions. According to data released by the government, Maharashtra, as on September 13, inoculated 67,891,518 people. As per the state government data, 23,720,298 individuals aged between 18 and 44 years received their first vaccine dose and 3,451,618 received their second dose since the inoculation drive for this age group began on May 1.
30th September 2021 | The Times of India
More than 2.7 million doses have been distributed across the state for the 12-hour mega vaccination drive in 40,000 government centres that aim to vaccinate at least 2 million people. So far, at least 46 of the eligible adults in the state have taken at least one dose of the vaccine, while 12% of them have completed the course.
7th September 2021 | India Today
Karnataka Health and Medical Education Minister said that 23 district administrations have been given a target to speed up vaccination coverage and complete the first dose for adults by the end of September. Further, targets were set to ensure full adult vaccinations by the end of November.
9th September 2021 | The Straits Times
Malaysia has fully vaccinated 50.5 percent of its total population by the end of September 8, official data showed. At least 64.1 per cent of the Malaysian population of 32 million have received at least one dose of a COVID-19 vaccine, said the Special Committee for Ensuring Access to COVID-19 Vaccine Supply in a tweet. Officials say 97.8 per cent of people in Klang Valley have completed their COVID-19 inoculations.
9th September 2021 | Malaysia Now
China’s Sinovac Biotech will trial its COVID-19 vaccine in children and adolescents in Malaysia as part of a global Phase III study. The study will evaluate the efficacy, immunogenicity and safety of the CoronaVac vaccine on children and adolescents aged six months to 17 years, the firms said in a statement. The global trial will enrol 14,000 participants across Chile, the Philippines, Malaysia, Kenya and South Africa.